Evaluation of Plasma Lipocalin-2 as a Predictor of Etiology and Severity in Adult Patients with Community-Acquired Pneumonia
The aim of this study was to evaluate the diagnostic performance of plasma Lipocalin-2 (LCN2) concentration in adult patients with community-acquired pneumonia (CAP) to determine its etiology, severity and prognosis. A prospective observational study involving adults with CAP from November 2015 to M...
Main Authors: | Lucía Boix-Palop, Andrea Vergara, Emma Padilla, Diego Martínez, Ana Blanco, Josefa Pérez, Esther Calbo, Jordi Vila, Climent Casals-Pascual |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/11/5/1160 |
Similar Items
-
23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type <i>Streptococcus pneumoniae</i>
by: Thomas Chandler, et al.
Published: (2022-03-01) -
Fatal Community-Acquired Pneumonia: 18 Years in a Medical Center
by: Ling-Jen Wang, et al.
Published: (2013-02-01) -
Host genetic variants associated with susceptibility and severity of pneumococcal pneumonia in adult patients
by: Lucía Boix-Palop, et al.
Published: (2023-12-01) -
Observed costs and health care use of children in a prospective cohort study on community-acquired pneumonia in Geneva, Switzerland
by: Kristina Keitel, et al.
Published: (2014-03-01) -
Effect of vaccination on morbidity and mortality from community-acquired pneumonia
by: T. A. Bayanova, et al.
Published: (2024-03-01)